{"gene":"GREM2","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1998,"finding":"GREM2 (PRDC) was identified as a novel secreted protein with limited similarity to DAN and cerberus, containing a signal peptide and expressed in commissural neurons of the developing spinal cord, suggesting a role in neural development.","method":"Gene trap in ES cells, lacZ reporter, cDNA structural analysis","journal":"Development, growth & differentiation","confidence":"Medium","confidence_rationale":"Tier 2 — direct genetic/reporter experiment establishing expression and secreted nature, single lab","pmids":["9639362"],"is_preprint":false},{"year":2004,"finding":"GREM2 (CKTSF1B2/PRDC) was identified as a secreted BMP antagonist of the DAN family, defined by a conserved N-terminal signal peptide and DAN domain with nine cysteine residues, mapped to human chromosome 1q43.","method":"Bioinformatics/in silico sequence analysis and phylogenetic analysis","journal":"Oncology reports","confidence":"Low","confidence_rationale":"Tier 4 — computational prediction only","pmids":["15254711"],"is_preprint":false},{"year":2006,"finding":"In zebrafish, PRDC (GREM2 ortholog) is expressed as a secreted glycoprotein in developing eyes, pharyngeal arches, somites, and swim bladder, consistent with roles in eye development, pharyngeal arch remodeling, somitogenesis, and swim bladder organogenesis.","method":"In situ hybridization, developmental expression analysis in zebrafish","journal":"Developmental dynamics","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization by in situ hybridization in zebrafish ortholog; single lab","pmids":["16921498"],"is_preprint":false},{"year":2007,"finding":"GREM2 (PRDC) expression is specifically induced by Wnt/β-catenin signaling in a Tcf/LEF-independent manner; the secreted PRDC protein then antagonizes BMP-4 signaling but does not inhibit Wnt signaling, placing GREM2 as a mediator that antagonizes BMP-4 downstream of Wnt.","method":"Microarray, reporter assays, conditioned media experiments, β-catenin overexpression","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional assays including conditioned media and reporter, single lab","pmids":["17222801"],"is_preprint":false},{"year":2008,"finding":"GREM2 (PRDC) is expressed in pre-osteoblasts, suppresses BMP-2-induced phospho-Smad1/5/8, inhibits osteoblast differentiation markers and mineralization; siRNA knockdown of PRDC elevates alkaline phosphatase activity, phospho-Smad1/5/8, and promotes bone-like mineralized matrix deposition in vitro.","method":"Adenoviral overexpression, siRNA knockdown, Western blotting for phospho-Smad1/5/8, alkaline phosphatase assay, mineralization assay in primary osteoblasts","journal":"Experimental cell research","confidence":"High","confidence_rationale":"Tier 1–2 — gain- and loss-of-function with multiple orthogonal readouts in primary cells, moderate evidence","pmids":["19073177"],"is_preprint":false},{"year":2009,"finding":"In chick, PRDC (GREM2 ortholog) modulates BMP signaling in the pharyngeal pouches to regulate epibranchial placode neurogenesis: gain-of-PRDC function reduces Bmp4 and inhibits placode neurogenesis, while loss-of-PRDC function expands ectopic Bmp4 and placode neurogenesis.","method":"Gain- and loss-of-function experiments in chick embryos, in situ hybridization","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal gain/loss-of-function in vivo with defined molecular and cellular phenotype","pmids":["19836367"],"is_preprint":false},{"year":2012,"finding":"Recombinant mouse PRDC (GREM2) was expressed, purified, and shown to directly bind BMP2, BMP4, and BMP7 (but not activin A), and to inhibit BMP2 and BMP4 in a cell-based luciferase reporter assay; circular dichroism confirmed folded protein with helical content.","method":"Recombinant protein expression/purification from E. coli, binding assays, cell-based luciferase reporter assay, circular dichroism","journal":"Protein expression and purification","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with direct binding and functional assays","pmids":["22381466"],"is_preprint":false},{"year":2012,"finding":"In zebrafish, GREM2 regulates cardiac laterality and atrial cardiomyocyte differentiation through BMP signaling; the Q76E variant has increased BMP-inhibitory activity; GREM2 overactivity causes slower cardiac contraction and induces atrial-specific genes (connexin-40, sarcolipin, atrial natriuretic peptide) in mouse ES cells.","method":"Zebrafish overexpression, live heart imaging, mouse ES cell differentiation, sequencing of AF probands","journal":"Disease models & mechanisms","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods across two model organisms, with functional variant characterization","pmids":["23223679"],"is_preprint":false},{"year":2014,"finding":"Grem2-null mice develop malformed mandibular and maxillary incisors, demonstrating that GREM2 is required for normal tooth morphogenesis in vivo.","method":"Grem2-knockout mouse model, histology, DEXA scanning","journal":"Veterinary pathology","confidence":"High","confidence_rationale":"Tier 2 — clean KO mouse with defined organ-specific phenotype","pmids":["24686385"],"is_preprint":false},{"year":2016,"finding":"GREM1 and GREM2 modulate BMP2/4 signaling in human fetal ovarian somatic cells in a gene-specific manner, antagonizing the BMP-induced transcription of some target genes (including LGR5) but not others, fine-tuning BMP signal intensity during ovarian development.","method":"Primary human fetal ovarian somatic cell culture, recombinant GREM1/GREM2 treatment, qRT-PCR, immunoblotting","journal":"Molecular human reproduction","confidence":"Medium","confidence_rationale":"Tier 2 — direct cell-based functional assay with primary human cells, single lab","pmids":["27385727"],"is_preprint":false},{"year":2016,"finding":"Treatment of mouse embryonic stem cell embryoid bodies with Grem2 protein directs differentiation toward atrial cardiomyocytes with atrial-like molecular, histological, and electrophysiological characteristics.","method":"Mouse ES cell differentiation protocol, Myh6-DSRed reporter, molecular/histological/electrophysiological analyses","journal":"Journal of visualized experiments : JoVE","confidence":"Medium","confidence_rationale":"Tier 2 — direct functional assay with multiple phenotypic readouts, single lab protocol paper","pmids":["27023256"],"is_preprint":false},{"year":2017,"finding":"Mutagenesis and heparin-binding measurements identified specific lysine residues on Grem2 that mediate heparin/heparan sulfate (HS) binding; these residues are not required for BMP antagonism; the Grem2 heparin/HS and BMP-binding epitopes are independent; the Grem2–BMP2 complex has higher heparin affinity than either protein alone.","method":"Site-directed mutagenesis, heparin-binding measurements, cell surface-binding analysis, in vitro protein–protein interaction assays","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with quantitative binding assays, multiple orthogonal methods","pmids":["28104757"],"is_preprint":false},{"year":2019,"finding":"Grem2 overexpression in human podocytes increases phospho-Smad2/3 and decreases phospho-Smad1/5/8, promotes apoptosis (elevated Bax/Bcl2 ratio); Smad2/3 inhibition (SIS3) and BMP-7 (Smad1/5/8 agonist) attenuate Grem2-induced apoptosis, placing Grem2 upstream of Smad signaling in podocyte apoptosis.","method":"Plasmid transfection overexpression, siRNA knockdown, Western blotting for phospho-Smads, apoptosis assays, pharmacological inhibitors","journal":"Biochimie","confidence":"Medium","confidence_rationale":"Tier 2 — gain/loss-of-function with pathway epistasis via pharmacological tools, single lab","pmids":["30831151"],"is_preprint":false},{"year":2021,"finding":"GREM2 increases LATS2 activity and YAP phosphorylation/degradation in liver cancer cells, suppressing migration and invasion; FOXA2 transcriptionally suppresses miR-103a-3p, which directly targets the GREM2 3'UTR, placing FOXA2→miR-103a-3p→GREM2→LATS2/YAP as a pathway controlling liver cancer cell motility.","method":"ChIP assay, luciferase reporter assay, Western blotting, migration/invasion assays, siRNA and overexpression experiments","journal":"Cytotechnology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods establishing pathway hierarchy, single lab","pmids":["34349344"],"is_preprint":false},{"year":2021,"finding":"A GREM2 tooth-agenesis-associated variant (rs1414655) reduces GREM2 transcriptional activity and decreases MSX1 expression, and increases cell migration in dental stem cells (SHED), demonstrating functional consequences of this variant on tooth development gene networks.","method":"Plasmid transfection of reference and mutant alleles in SHED cells, luciferase reporter assay, qRT-PCR, cell migration assay","journal":"Orthodontics & craniofacial research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional readouts with mutant vs. reference allele comparison, single lab","pmids":["33369218"],"is_preprint":false},{"year":2022,"finding":"Grem2 inhibits the browning program of visceral preadipocytes by antagonizing BMP4/7-SMAD1/5/8 signaling via BMPR2; Grem2 overexpression in mice reduces visceral fat browning, while Grem2 ablation enhances browning capacity and reduces visceral fat content; preadipocyte-specific Bmpr2 knockout abolishes the antagonistic effect of Grem2.","method":"Recombinant Grem2 protein, Grem2 overexpression and knockout mouse models, preadipocyte-specific Bmpr2 KO mice, Western blotting for SMAD1/5/8, adipocyte browning assays, ELISA","journal":"EBioMedicine","confidence":"High","confidence_rationale":"Tier 1–2 — multiple genetic models (OE, KO, tissue-specific KO) plus recombinant protein with defined molecular pathway","pmids":["35349825"],"is_preprint":false},{"year":2022,"finding":"PRDC (GREM2) decreases in hypertensive lungs; exogenous PRDC reverses BMP2/4-mediated inhibition of smooth muscle cell proliferation and migration and promotion of apoptosis in vitro, and PRDC supplementation worsens pulmonary arterial hypertension in vivo, indicating a compensatory protective role of PRDC downregulation in PAH.","method":"Human lung samples, monocrotaline rat PAH model, in vitro PASMC proliferation/migration/apoptosis assays, in vivo PRDC supplementation, hemodynamic measurements","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro and in vivo functional assays with defined cellular phenotypes, single lab","pmids":["35414785"],"is_preprint":false},{"year":2024,"finding":"Partial Grem2 inactivation in female mice increases trabecular bone mineral density and trabecular thickness without changing cortical thickness; Grem2 deletion stimulates osteoblast differentiation (elevated Alp, Bglap, Sp7 mRNA after BMP-2 stimulation), confirming GREM2 as a negative regulator of osteoblast differentiation and trabecular bone formation acting via BMP-2 signaling.","method":"Grem2+/- and Grem2-/- mouse models, microCT, DEXA, primary osteoblast culture with BMP-2 stimulation, qRT-PCR","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 — clean genetic mouse models with multiple skeletal and cellular readouts, replicating prior osteoblast findings","pmids":["38839844"],"is_preprint":false},{"year":2025,"finding":"GREM2 is a downstream transcriptional target of STAT3; dual-luciferase assay and siRNA interference confirmed STAT3 drives GREM2 expression; in LPS-stimulated thyroid cells, dexamethasone inhibits STAT3 phosphorylation, reducing GREM2 expression and downstream proinflammatory cytokines (TNF-α, IL-1β, CCL2).","method":"Dual-luciferase assay, siRNA interference, phospho-STAT3 Western blotting, in vitro LPS-stimulated thyroid cell model","journal":"ACS omega","confidence":"Medium","confidence_rationale":"Tier 2 — direct reporter and siRNA validation of STAT3→GREM2 axis, single lab","pmids":["41322616"],"is_preprint":false}],"current_model":"GREM2 (also known as PRDC) is a secreted BMP antagonist of the DAN family that directly binds BMP2, BMP4, and BMP7 via a cysteine-knot domain; it suppresses BMP/SMAD1/5/8 signaling to inhibit osteoblast differentiation, visceral fat browning, and atrial cardiomyocyte specification (while promoting Smad2/3-dependent apoptosis in some contexts), and its expression is induced by Wnt/β-catenin and STAT3 signaling, regulated by heparin/heparan sulfate interactions, and required in vivo for tooth morphogenesis, cardiac laterality, and atrial chamber formation."},"narrative":{"teleology":[{"year":1998,"claim":"The initial discovery of GREM2 (PRDC) established it as a novel secreted protein of the DAN family expressed in the developing nervous system, raising the question of its molecular function.","evidence":"Gene trap in mouse ES cells with lacZ reporter and cDNA structural analysis","pmids":["9639362"],"confidence":"Medium","gaps":["No functional assay performed","Binding partners not identified","Relationship to BMP signaling unknown"]},{"year":2007,"claim":"Connecting GREM2 to upstream Wnt signaling established that β-catenin induces GREM2 expression, which then antagonizes BMP-4 — placing GREM2 as a Wnt-to-BMP signaling intermediary.","evidence":"Microarray, reporter assays, conditioned media, and β-catenin overexpression in cell lines","pmids":["17222801"],"confidence":"Medium","gaps":["Tcf/LEF-independent mechanism of induction not molecularly defined","In vivo relevance of Wnt→GREM2→BMP axis not tested"]},{"year":2008,"claim":"Gain- and loss-of-function experiments in primary osteoblasts demonstrated that GREM2 suppresses BMP-2-induced SMAD1/5/8 phosphorylation and osteoblast differentiation, defining its cell-autonomous role in bone biology.","evidence":"Adenoviral overexpression and siRNA knockdown in primary osteoblasts with Western blot, ALP, and mineralization assays","pmids":["19073177"],"confidence":"High","gaps":["In vivo skeletal phenotype of GREM2 loss not yet shown","Relative contributions of BMP2 vs BMP4 vs BMP7 antagonism in bone not dissected"]},{"year":2009,"claim":"In vivo gain/loss-of-function in chick demonstrated GREM2 modulates BMP signaling in pharyngeal pouches to regulate epibranchial placode neurogenesis, confirming its developmental BMP-antagonist role in a whole-organism context.","evidence":"Reciprocal gain- and loss-of-function in chick embryos with in situ hybridization","pmids":["19836367"],"confidence":"High","gaps":["Mammalian relevance of pharyngeal arch function not confirmed","Receptor-level mechanism not defined"]},{"year":2012,"claim":"Biochemical reconstitution established that GREM2 directly binds BMP2, BMP4, and BMP7 (but not activin A), confirming ligand specificity, while zebrafish and mouse ES cell work revealed its role in cardiac laterality and atrial cardiomyocyte differentiation.","evidence":"Recombinant protein binding assays and cell-based reporter (PMID:22381466); zebrafish overexpression, live cardiac imaging, and mouse ES cell differentiation (PMID:23223679)","pmids":["22381466","23223679"],"confidence":"High","gaps":["Structural basis of BMP-binding selectivity unknown","Whether cardiac role requires BMP antagonism specifically vs. other mechanisms not formally tested"]},{"year":2014,"claim":"Grem2-null mice revealed a requirement for GREM2 in tooth morphogenesis, providing the first mammalian knockout phenotype.","evidence":"Grem2-knockout mouse with histological and DEXA analysis","pmids":["24686385"],"confidence":"High","gaps":["Full skeletal phenotype not deeply characterized in this study","Cardiac phenotype of knockout not reported"]},{"year":2017,"claim":"Mutagenesis dissected the GREM2 protein into functionally independent heparin/heparan sulfate–binding and BMP-binding epitopes, showing the GREM2–BMP2 complex has enhanced heparin affinity, suggesting extracellular matrix interactions regulate GREM2 bioavailability.","evidence":"Site-directed mutagenesis of lysine residues, heparin-binding quantification, cell-surface binding, and protein–protein interaction assays","pmids":["28104757"],"confidence":"High","gaps":["In vivo significance of heparan sulfate interaction for GREM2 gradient/activity not tested","No structural model of GREM2–BMP complex available"]},{"year":2019,"claim":"GREM2 overexpression in podocytes was shown to shift SMAD signaling from SMAD1/5/8 toward SMAD2/3, promoting apoptosis — revealing a context-dependent pro-apoptotic output of BMP antagonism.","evidence":"Overexpression and siRNA in human podocytes, phospho-SMAD Western blots, apoptosis assays, Smad2/3 inhibitor epistasis","pmids":["30831151"],"confidence":"Medium","gaps":["Mechanism by which GREM2 activates SMAD2/3 not defined (direct vs indirect)","In vivo renal phenotype not tested"]},{"year":2022,"claim":"Multiple genetic models established GREM2 as a physiological inhibitor of visceral fat browning via BMPR2-dependent SMAD1/5/8 antagonism, while separately its downregulation was shown to be protective in pulmonary arterial hypertension.","evidence":"Grem2 overexpression and knockout mice, preadipocyte-specific Bmpr2 KO (PMID:35349825); monocrotaline PAH rat model and human lung samples (PMID:35414785)","pmids":["35349825","35414785"],"confidence":"High","gaps":["Whether GREM2 acts on brown vs white preadipocytes via identical mechanisms unclear","Human genetic validation of GREM2 in metabolic disease lacking"]},{"year":2024,"claim":"Grem2 haploinsufficiency in female mice increased trabecular bone mineral density and osteoblast differentiation markers upon BMP-2 stimulation, confirming GREM2 as a dose-sensitive negative regulator of bone formation.","evidence":"Grem2+/- and Grem2-/- mouse models, microCT, DEXA, primary osteoblast culture with BMP-2","pmids":["38839844"],"confidence":"High","gaps":["Sex-specific mechanism not explained","Cortical bone unaffected — basis of compartment specificity unknown"]},{"year":2025,"claim":"STAT3 was identified as a direct transcriptional activator of GREM2, linking inflammatory signaling to GREM2 expression in thyroid cells.","evidence":"Dual-luciferase reporter assay and siRNA against STAT3 in LPS-stimulated thyroid cell model","pmids":["41322616"],"confidence":"Medium","gaps":["Whether STAT3→GREM2 axis operates in other tissues not tested","Promoter elements mediating STAT3 binding not mapped at base-pair resolution"]},{"year":null,"claim":"A high-resolution structure of GREM2 alone and in complex with BMP ligands is lacking, and the mechanism by which GREM2 selectively antagonizes BMP2/4/7 but not activin A remains structurally undefined; additionally, the cardiac-specific in vivo consequences of GREM2 loss in mammals have not been reported.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal or cryo-EM structure of GREM2 or GREM2–BMP complex","Mammalian cardiac knockout phenotype not reported","Relative in vivo contributions of heparan sulfate sequestration vs direct BMP binding not dissected"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[4,5,6,7,9,12,15,16,17]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,2,6,11]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,4,5,6,7,12,15,16,17]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[5,7,8,14]}],"complexes":[],"partners":["BMP2","BMP4","BMP7","BMPR2"],"other_free_text":[]},"mechanistic_narrative":"GREM2 (also known as PRDC) is a secreted BMP antagonist of the DAN/cerberus family that functions as a key modulator of BMP/SMAD signaling across multiple developmental and homeostatic contexts. GREM2 directly binds BMP2, BMP4, and BMP7 through its cysteine-knot domain, suppressing canonical BMP-induced phospho-SMAD1/5/8 signaling, and its heparin/heparan sulfate–binding and BMP-binding epitopes are independent, with the GREM2–BMP2 complex exhibiting enhanced heparin affinity [PMID:22381466, PMID:28104757]. Through BMP antagonism, GREM2 negatively regulates osteoblast differentiation and trabecular bone formation, inhibits visceral fat browning via BMPR2-dependent SMAD1/5/8 suppression, directs atrial cardiomyocyte specification and cardiac laterality, and is required for normal tooth morphogenesis [PMID:19073177, PMID:38839844, PMID:35349825, PMID:23223679, PMID:24686385]. GREM2 expression is induced by Wnt/β-catenin signaling in a Tcf/LEF-independent manner and by STAT3, and in podocytes GREM2 overexpression shifts signaling toward phospho-SMAD2/3 to promote apoptosis [PMID:17222801, PMID:41322616, PMID:30831151]."},"prefetch_data":{"uniprot":{"accession":"Q9H772","full_name":"Gremlin-2","aliases":["Cysteine knot superfamily 1, BMP antagonist 2","DAN domain family member 3","Protein related to DAN and cerberus"],"length_aa":168,"mass_kda":19.3,"function":"Cytokine that inhibits the activity of BMP2 and BMP4 in a dose-dependent manner, and thereby modulates signaling by BMP family members. Contributes to the regulation of embryonic morphogenesis via BMP family members. Antagonizes BMP4-induced suppression of progesterone production in granulosa cells","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/Q9H772/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GREM2","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GREM2","total_profiled":1310},"omim":[{"mim_id":"617275","title":"TOOTH AGENESIS, SELECTIVE, 9; STHAG9","url":"https://www.omim.org/entry/617275"},{"mim_id":"608832","title":"GREMLIN 2, DAN FAMILY BMP ANTAGONIST; GREM2","url":"https://www.omim.org/entry/608832"},{"mim_id":"106600","title":"TOOTH AGENESIS, SELECTIVE, 1; STHAG1","url":"https://www.omim.org/entry/106600"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"gallbladder","ntpm":29.4},{"tissue":"liver","ntpm":24.6}],"url":"https://www.proteinatlas.org/search/GREM2"},"hgnc":{"alias_symbol":["Prdc","FLJ21195","CKTSF1B2","DAND3"],"prev_symbol":[]},"alphafold":{"accession":"Q9H772","domains":[{"cath_id":"2.10.90.10","chopping":"69-162","consensus_level":"medium","plddt":92.7907,"start":69,"end":162}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H772","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H772-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H772-F1-predicted_aligned_error_v6.png","plddt_mean":79.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GREM2","jax_strain_url":"https://www.jax.org/strain/search?query=GREM2"},"sequence":{"accession":"Q9H772","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9H772.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9H772/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H772"}},"corpus_meta":[{"pmid":"33144675","id":"PMC_33144675","title":"Cancer-associated fibroblast-secreted exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-β signaling pathway.","date":"2020","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33144675","citation_count":102,"is_preprint":false},{"pmid":"37422021","id":"PMC_37422021","title":"SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis.","date":"2023","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/37422021","citation_count":91,"is_preprint":false},{"pmid":"9639362","id":"PMC_9639362","title":"Sequence and expression of a novel mouse gene PRDC (protein related to DAN and cerberus) identified by a gene trap approach.","date":"1998","source":"Development, growth & differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/9639362","citation_count":49,"is_preprint":false},{"pmid":"15254711","id":"PMC_15254711","title":"Identification and characterization of human CKTSF1B2 and CKTSF1B3 genes in silico.","date":"2004","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/15254711","citation_count":48,"is_preprint":false},{"pmid":"19073177","id":"PMC_19073177","title":"Protein related to DAN and cerberus (PRDC) inhibits osteoblastic differentiation and its suppression promotes osteogenesis in vitro.","date":"2008","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/19073177","citation_count":47,"is_preprint":false},{"pmid":"23223679","id":"PMC_23223679","title":"Functional modeling in zebrafish demonstrates that the atrial-fibrillation-associated gene GREM2 regulates cardiac laterality, cardiomyocyte differentiation and atrial rhythm.","date":"2012","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/23223679","citation_count":44,"is_preprint":false},{"pmid":"27385727","id":"PMC_27385727","title":"BMP signalling in human fetal ovary somatic cells is modulated in a gene-specific fashion by GREM1 and GREM2.","date":"2016","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/27385727","citation_count":28,"is_preprint":false},{"pmid":"17222801","id":"PMC_17222801","title":"Wnt/beta-catenin signaling regulates expression of PRDC, an antagonist of the BMP-4 signaling pathway.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17222801","citation_count":27,"is_preprint":false},{"pmid":"16921498","id":"PMC_16921498","title":"Expression of the protein related to Dan and Cerberus gene--prdc--During eye, pharyngeal arch, somite, and swim bladder development in zebrafish.","date":"2006","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16921498","citation_count":27,"is_preprint":false},{"pmid":"34049478","id":"PMC_34049478","title":"LncRNA DNM3OS regulates GREM2 via miR-127-5p to suppress early chondrogenic differentiation of rat mesenchymal stem cells under hypoxic conditions.","date":"2021","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/34049478","citation_count":26,"is_preprint":false},{"pmid":"19836367","id":"PMC_19836367","title":"PRDC regulates placode neurogenesis in chick by modulating BMP signalling.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19836367","citation_count":25,"is_preprint":false},{"pmid":"24686385","id":"PMC_24686385","title":"Malformation of incisor teeth in Grem2⁻/⁻ mice.","date":"2014","source":"Veterinary pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24686385","citation_count":24,"is_preprint":false},{"pmid":"35619575","id":"PMC_35619575","title":"MiR-103a-3p Contributes to the Progression of Colorectal Cancer by Regulating GREM2 Expression.","date":"2022","source":"Yonsei medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/35619575","citation_count":16,"is_preprint":false},{"pmid":"30831151","id":"PMC_30831151","title":"Grem2 mediates podocyte apoptosis in high glucose milieu.","date":"2019","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/30831151","citation_count":16,"is_preprint":false},{"pmid":"34973370","id":"PMC_34973370","title":"miR-122-5p targets GREM2 to protect against glucocorticoid-induced endothelial damage through the BMP signaling pathway.","date":"2021","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/34973370","citation_count":15,"is_preprint":false},{"pmid":"30246922","id":"PMC_30246922","title":"Further evidence for the role of WNT10A, WNT10B and GREM2 as candidate genes for isolated tooth agenesis.","date":"2018","source":"Orthodontics & craniofacial research","url":"https://pubmed.ncbi.nlm.nih.gov/30246922","citation_count":13,"is_preprint":false},{"pmid":"23902946","id":"PMC_23902946","title":"Genetic variants in GREM2 are associated with bone mineral density in a southern Chinese population.","date":"2013","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/23902946","citation_count":13,"is_preprint":false},{"pmid":"31345097","id":"PMC_31345097","title":"GREM2 maintains stem cell-like phenotypes in gastric cancer cells by regulating the JNK signaling pathway.","date":"2019","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/31345097","citation_count":12,"is_preprint":false},{"pmid":"28992378","id":"PMC_28992378","title":"GREM2 nucleotide variants and the risk of tooth agenesis.","date":"2017","source":"Oral diseases","url":"https://pubmed.ncbi.nlm.nih.gov/28992378","citation_count":12,"is_preprint":false},{"pmid":"28104757","id":"PMC_28104757","title":"Analysis and identification of the Grem2 heparin/heparan sulfate-binding motif.","date":"2017","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/28104757","citation_count":11,"is_preprint":false},{"pmid":"34349344","id":"PMC_34349344","title":"Inhibiting roles of FOXA2 in liver cancer cell migration and invasion by transcriptionally suppressing microRNA-103a-3p and activating the GREM2/LATS2/YAP axis.","date":"2021","source":"Cytotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/34349344","citation_count":11,"is_preprint":false},{"pmid":"22381466","id":"PMC_22381466","title":"Expression and purification of recombinant protein related to DAN and cerberus (PRDC).","date":"2012","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/22381466","citation_count":9,"is_preprint":false},{"pmid":"35349825","id":"PMC_35349825","title":"GREM2 is associated with human central obesity and inhibits visceral preadipocyte browning.","date":"2022","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/35349825","citation_count":8,"is_preprint":false},{"pmid":"33369218","id":"PMC_33369218","title":"Functional characterization of ATF1, GREM2 AND WNT10B variants associated with tooth agenesis.","date":"2021","source":"Orthodontics & craniofacial research","url":"https://pubmed.ncbi.nlm.nih.gov/33369218","citation_count":6,"is_preprint":false},{"pmid":"35414785","id":"PMC_35414785","title":"Compensatory roles of Protein Related to DAN and Cerberus (PRDC) decrease in pulmonary arterial hypertension.","date":"2022","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35414785","citation_count":5,"is_preprint":false},{"pmid":"27023256","id":"PMC_27023256","title":"Differentiation of Atrial Cardiomyocytes from Pluripotent Stem Cells Using the BMP Antagonist Grem2.","date":"2016","source":"Journal of visualized experiments : JoVE","url":"https://pubmed.ncbi.nlm.nih.gov/27023256","citation_count":4,"is_preprint":false},{"pmid":"38941907","id":"PMC_38941907","title":"6-Shogaol alleviates high-fat diet induced hepatic steatosis through miR-3066-5p/Grem2 pathway.","date":"2024","source":"Food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38941907","citation_count":3,"is_preprint":false},{"pmid":"40500779","id":"PMC_40500779","title":"Overexpression of miR-671-3p alleviates postmenopausal osteoporosis by targeting GREM2 to activate BMP2/SMAD signaling pathway.","date":"2025","source":"Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/40500779","citation_count":2,"is_preprint":false},{"pmid":"39757007","id":"PMC_39757007","title":"Mesenchymal Stem Cells Mediated Suppression of GREM2 Inhibits Renal Epithelial-Mesenchymal Transition and Attenuates the Progression of Diabetic Kidney Disease.","date":"2025","source":"International journal of stem cells","url":"https://pubmed.ncbi.nlm.nih.gov/39757007","citation_count":2,"is_preprint":false},{"pmid":"38839844","id":"PMC_38839844","title":"GREM2 inactivation increases trabecular bone mass in mice.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/38839844","citation_count":2,"is_preprint":false},{"pmid":"41322616","id":"PMC_41322616","title":"Integrative Transcriptome and Machine Learning Analysis Uncovers Critical STAT3/GREM2 Signaling Mechanisms in Dexamethasone Treatment of Hashimoto's Thyroiditis.","date":"2025","source":"ACS omega","url":"https://pubmed.ncbi.nlm.nih.gov/41322616","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.07.25325355","title":"Hierarchical representation learning of preeclampsia interactome connecting endometrial maturation, placentation, chorioamnionitis, and HELLP syndrome","date":"2025-04-07","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.07.25325355","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.06.26.600819","title":"Biofilm formation in<i>Streptococcus suis</i>:<i>In vitro</i>impact of serovar and assessment of coinfections with other porcine respiratory disease complex bacterial pathogens","date":"2024-06-27","source":"bioRxiv","url":"https://doi.org/10.1101/2024.06.26.600819","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":19062,"output_tokens":4324,"usd":0.061023},"stage2":{"model":"claude-opus-4-6","input_tokens":7835,"output_tokens":2771,"usd":0.162675},"total_usd":0.223698,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"GREM2 (PRDC) was identified as a novel secreted protein with limited similarity to DAN and cerberus, containing a signal peptide and expressed in commissural neurons of the developing spinal cord, suggesting a role in neural development.\",\n      \"method\": \"Gene trap in ES cells, lacZ reporter, cDNA structural analysis\",\n      \"journal\": \"Development, growth & differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct genetic/reporter experiment establishing expression and secreted nature, single lab\",\n      \"pmids\": [\"9639362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GREM2 (CKTSF1B2/PRDC) was identified as a secreted BMP antagonist of the DAN family, defined by a conserved N-terminal signal peptide and DAN domain with nine cysteine residues, mapped to human chromosome 1q43.\",\n      \"method\": \"Bioinformatics/in silico sequence analysis and phylogenetic analysis\",\n      \"journal\": \"Oncology reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational prediction only\",\n      \"pmids\": [\"15254711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In zebrafish, PRDC (GREM2 ortholog) is expressed as a secreted glycoprotein in developing eyes, pharyngeal arches, somites, and swim bladder, consistent with roles in eye development, pharyngeal arch remodeling, somitogenesis, and swim bladder organogenesis.\",\n      \"method\": \"In situ hybridization, developmental expression analysis in zebrafish\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization by in situ hybridization in zebrafish ortholog; single lab\",\n      \"pmids\": [\"16921498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GREM2 (PRDC) expression is specifically induced by Wnt/β-catenin signaling in a Tcf/LEF-independent manner; the secreted PRDC protein then antagonizes BMP-4 signaling but does not inhibit Wnt signaling, placing GREM2 as a mediator that antagonizes BMP-4 downstream of Wnt.\",\n      \"method\": \"Microarray, reporter assays, conditioned media experiments, β-catenin overexpression\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays including conditioned media and reporter, single lab\",\n      \"pmids\": [\"17222801\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GREM2 (PRDC) is expressed in pre-osteoblasts, suppresses BMP-2-induced phospho-Smad1/5/8, inhibits osteoblast differentiation markers and mineralization; siRNA knockdown of PRDC elevates alkaline phosphatase activity, phospho-Smad1/5/8, and promotes bone-like mineralized matrix deposition in vitro.\",\n      \"method\": \"Adenoviral overexpression, siRNA knockdown, Western blotting for phospho-Smad1/5/8, alkaline phosphatase assay, mineralization assay in primary osteoblasts\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — gain- and loss-of-function with multiple orthogonal readouts in primary cells, moderate evidence\",\n      \"pmids\": [\"19073177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In chick, PRDC (GREM2 ortholog) modulates BMP signaling in the pharyngeal pouches to regulate epibranchial placode neurogenesis: gain-of-PRDC function reduces Bmp4 and inhibits placode neurogenesis, while loss-of-PRDC function expands ectopic Bmp4 and placode neurogenesis.\",\n      \"method\": \"Gain- and loss-of-function experiments in chick embryos, in situ hybridization\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain/loss-of-function in vivo with defined molecular and cellular phenotype\",\n      \"pmids\": [\"19836367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Recombinant mouse PRDC (GREM2) was expressed, purified, and shown to directly bind BMP2, BMP4, and BMP7 (but not activin A), and to inhibit BMP2 and BMP4 in a cell-based luciferase reporter assay; circular dichroism confirmed folded protein with helical content.\",\n      \"method\": \"Recombinant protein expression/purification from E. coli, binding assays, cell-based luciferase reporter assay, circular dichroism\",\n      \"journal\": \"Protein expression and purification\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with direct binding and functional assays\",\n      \"pmids\": [\"22381466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In zebrafish, GREM2 regulates cardiac laterality and atrial cardiomyocyte differentiation through BMP signaling; the Q76E variant has increased BMP-inhibitory activity; GREM2 overactivity causes slower cardiac contraction and induces atrial-specific genes (connexin-40, sarcolipin, atrial natriuretic peptide) in mouse ES cells.\",\n      \"method\": \"Zebrafish overexpression, live heart imaging, mouse ES cell differentiation, sequencing of AF probands\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods across two model organisms, with functional variant characterization\",\n      \"pmids\": [\"23223679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Grem2-null mice develop malformed mandibular and maxillary incisors, demonstrating that GREM2 is required for normal tooth morphogenesis in vivo.\",\n      \"method\": \"Grem2-knockout mouse model, histology, DEXA scanning\",\n      \"journal\": \"Veterinary pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO mouse with defined organ-specific phenotype\",\n      \"pmids\": [\"24686385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GREM1 and GREM2 modulate BMP2/4 signaling in human fetal ovarian somatic cells in a gene-specific manner, antagonizing the BMP-induced transcription of some target genes (including LGR5) but not others, fine-tuning BMP signal intensity during ovarian development.\",\n      \"method\": \"Primary human fetal ovarian somatic cell culture, recombinant GREM1/GREM2 treatment, qRT-PCR, immunoblotting\",\n      \"journal\": \"Molecular human reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct cell-based functional assay with primary human cells, single lab\",\n      \"pmids\": [\"27385727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Treatment of mouse embryonic stem cell embryoid bodies with Grem2 protein directs differentiation toward atrial cardiomyocytes with atrial-like molecular, histological, and electrophysiological characteristics.\",\n      \"method\": \"Mouse ES cell differentiation protocol, Myh6-DSRed reporter, molecular/histological/electrophysiological analyses\",\n      \"journal\": \"Journal of visualized experiments : JoVE\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional assay with multiple phenotypic readouts, single lab protocol paper\",\n      \"pmids\": [\"27023256\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Mutagenesis and heparin-binding measurements identified specific lysine residues on Grem2 that mediate heparin/heparan sulfate (HS) binding; these residues are not required for BMP antagonism; the Grem2 heparin/HS and BMP-binding epitopes are independent; the Grem2–BMP2 complex has higher heparin affinity than either protein alone.\",\n      \"method\": \"Site-directed mutagenesis, heparin-binding measurements, cell surface-binding analysis, in vitro protein–protein interaction assays\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with quantitative binding assays, multiple orthogonal methods\",\n      \"pmids\": [\"28104757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Grem2 overexpression in human podocytes increases phospho-Smad2/3 and decreases phospho-Smad1/5/8, promotes apoptosis (elevated Bax/Bcl2 ratio); Smad2/3 inhibition (SIS3) and BMP-7 (Smad1/5/8 agonist) attenuate Grem2-induced apoptosis, placing Grem2 upstream of Smad signaling in podocyte apoptosis.\",\n      \"method\": \"Plasmid transfection overexpression, siRNA knockdown, Western blotting for phospho-Smads, apoptosis assays, pharmacological inhibitors\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain/loss-of-function with pathway epistasis via pharmacological tools, single lab\",\n      \"pmids\": [\"30831151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GREM2 increases LATS2 activity and YAP phosphorylation/degradation in liver cancer cells, suppressing migration and invasion; FOXA2 transcriptionally suppresses miR-103a-3p, which directly targets the GREM2 3'UTR, placing FOXA2→miR-103a-3p→GREM2→LATS2/YAP as a pathway controlling liver cancer cell motility.\",\n      \"method\": \"ChIP assay, luciferase reporter assay, Western blotting, migration/invasion assays, siRNA and overexpression experiments\",\n      \"journal\": \"Cytotechnology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods establishing pathway hierarchy, single lab\",\n      \"pmids\": [\"34349344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A GREM2 tooth-agenesis-associated variant (rs1414655) reduces GREM2 transcriptional activity and decreases MSX1 expression, and increases cell migration in dental stem cells (SHED), demonstrating functional consequences of this variant on tooth development gene networks.\",\n      \"method\": \"Plasmid transfection of reference and mutant alleles in SHED cells, luciferase reporter assay, qRT-PCR, cell migration assay\",\n      \"journal\": \"Orthodontics & craniofacial research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional readouts with mutant vs. reference allele comparison, single lab\",\n      \"pmids\": [\"33369218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Grem2 inhibits the browning program of visceral preadipocytes by antagonizing BMP4/7-SMAD1/5/8 signaling via BMPR2; Grem2 overexpression in mice reduces visceral fat browning, while Grem2 ablation enhances browning capacity and reduces visceral fat content; preadipocyte-specific Bmpr2 knockout abolishes the antagonistic effect of Grem2.\",\n      \"method\": \"Recombinant Grem2 protein, Grem2 overexpression and knockout mouse models, preadipocyte-specific Bmpr2 KO mice, Western blotting for SMAD1/5/8, adipocyte browning assays, ELISA\",\n      \"journal\": \"EBioMedicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple genetic models (OE, KO, tissue-specific KO) plus recombinant protein with defined molecular pathway\",\n      \"pmids\": [\"35349825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PRDC (GREM2) decreases in hypertensive lungs; exogenous PRDC reverses BMP2/4-mediated inhibition of smooth muscle cell proliferation and migration and promotion of apoptosis in vitro, and PRDC supplementation worsens pulmonary arterial hypertension in vivo, indicating a compensatory protective role of PRDC downregulation in PAH.\",\n      \"method\": \"Human lung samples, monocrotaline rat PAH model, in vitro PASMC proliferation/migration/apoptosis assays, in vivo PRDC supplementation, hemodynamic measurements\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo functional assays with defined cellular phenotypes, single lab\",\n      \"pmids\": [\"35414785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Partial Grem2 inactivation in female mice increases trabecular bone mineral density and trabecular thickness without changing cortical thickness; Grem2 deletion stimulates osteoblast differentiation (elevated Alp, Bglap, Sp7 mRNA after BMP-2 stimulation), confirming GREM2 as a negative regulator of osteoblast differentiation and trabecular bone formation acting via BMP-2 signaling.\",\n      \"method\": \"Grem2+/- and Grem2-/- mouse models, microCT, DEXA, primary osteoblast culture with BMP-2 stimulation, qRT-PCR\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic mouse models with multiple skeletal and cellular readouts, replicating prior osteoblast findings\",\n      \"pmids\": [\"38839844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GREM2 is a downstream transcriptional target of STAT3; dual-luciferase assay and siRNA interference confirmed STAT3 drives GREM2 expression; in LPS-stimulated thyroid cells, dexamethasone inhibits STAT3 phosphorylation, reducing GREM2 expression and downstream proinflammatory cytokines (TNF-α, IL-1β, CCL2).\",\n      \"method\": \"Dual-luciferase assay, siRNA interference, phospho-STAT3 Western blotting, in vitro LPS-stimulated thyroid cell model\",\n      \"journal\": \"ACS omega\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct reporter and siRNA validation of STAT3→GREM2 axis, single lab\",\n      \"pmids\": [\"41322616\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GREM2 (also known as PRDC) is a secreted BMP antagonist of the DAN family that directly binds BMP2, BMP4, and BMP7 via a cysteine-knot domain; it suppresses BMP/SMAD1/5/8 signaling to inhibit osteoblast differentiation, visceral fat browning, and atrial cardiomyocyte specification (while promoting Smad2/3-dependent apoptosis in some contexts), and its expression is induced by Wnt/β-catenin and STAT3 signaling, regulated by heparin/heparan sulfate interactions, and required in vivo for tooth morphogenesis, cardiac laterality, and atrial chamber formation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GREM2 (also known as PRDC) is a secreted BMP antagonist of the DAN/cerberus family that functions as a key modulator of BMP/SMAD signaling across multiple developmental and homeostatic contexts. GREM2 directly binds BMP2, BMP4, and BMP7 through its cysteine-knot domain, suppressing canonical BMP-induced phospho-SMAD1/5/8 signaling, and its heparin/heparan sulfate–binding and BMP-binding epitopes are independent, with the GREM2–BMP2 complex exhibiting enhanced heparin affinity [PMID:22381466, PMID:28104757]. Through BMP antagonism, GREM2 negatively regulates osteoblast differentiation and trabecular bone formation, inhibits visceral fat browning via BMPR2-dependent SMAD1/5/8 suppression, directs atrial cardiomyocyte specification and cardiac laterality, and is required for normal tooth morphogenesis [PMID:19073177, PMID:38839844, PMID:35349825, PMID:23223679, PMID:24686385]. GREM2 expression is induced by Wnt/β-catenin signaling in a Tcf/LEF-independent manner and by STAT3, and in podocytes GREM2 overexpression shifts signaling toward phospho-SMAD2/3 to promote apoptosis [PMID:17222801, PMID:41322616, PMID:30831151].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"The initial discovery of GREM2 (PRDC) established it as a novel secreted protein of the DAN family expressed in the developing nervous system, raising the question of its molecular function.\",\n      \"evidence\": \"Gene trap in mouse ES cells with lacZ reporter and cDNA structural analysis\",\n      \"pmids\": [\"9639362\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional assay performed\", \"Binding partners not identified\", \"Relationship to BMP signaling unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Connecting GREM2 to upstream Wnt signaling established that β-catenin induces GREM2 expression, which then antagonizes BMP-4 — placing GREM2 as a Wnt-to-BMP signaling intermediary.\",\n      \"evidence\": \"Microarray, reporter assays, conditioned media, and β-catenin overexpression in cell lines\",\n      \"pmids\": [\"17222801\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Tcf/LEF-independent mechanism of induction not molecularly defined\", \"In vivo relevance of Wnt→GREM2→BMP axis not tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Gain- and loss-of-function experiments in primary osteoblasts demonstrated that GREM2 suppresses BMP-2-induced SMAD1/5/8 phosphorylation and osteoblast differentiation, defining its cell-autonomous role in bone biology.\",\n      \"evidence\": \"Adenoviral overexpression and siRNA knockdown in primary osteoblasts with Western blot, ALP, and mineralization assays\",\n      \"pmids\": [\"19073177\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo skeletal phenotype of GREM2 loss not yet shown\", \"Relative contributions of BMP2 vs BMP4 vs BMP7 antagonism in bone not dissected\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"In vivo gain/loss-of-function in chick demonstrated GREM2 modulates BMP signaling in pharyngeal pouches to regulate epibranchial placode neurogenesis, confirming its developmental BMP-antagonist role in a whole-organism context.\",\n      \"evidence\": \"Reciprocal gain- and loss-of-function in chick embryos with in situ hybridization\",\n      \"pmids\": [\"19836367\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian relevance of pharyngeal arch function not confirmed\", \"Receptor-level mechanism not defined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Biochemical reconstitution established that GREM2 directly binds BMP2, BMP4, and BMP7 (but not activin A), confirming ligand specificity, while zebrafish and mouse ES cell work revealed its role in cardiac laterality and atrial cardiomyocyte differentiation.\",\n      \"evidence\": \"Recombinant protein binding assays and cell-based reporter (PMID:22381466); zebrafish overexpression, live cardiac imaging, and mouse ES cell differentiation (PMID:23223679)\",\n      \"pmids\": [\"22381466\", \"23223679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of BMP-binding selectivity unknown\", \"Whether cardiac role requires BMP antagonism specifically vs. other mechanisms not formally tested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Grem2-null mice revealed a requirement for GREM2 in tooth morphogenesis, providing the first mammalian knockout phenotype.\",\n      \"evidence\": \"Grem2-knockout mouse with histological and DEXA analysis\",\n      \"pmids\": [\"24686385\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full skeletal phenotype not deeply characterized in this study\", \"Cardiac phenotype of knockout not reported\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Mutagenesis dissected the GREM2 protein into functionally independent heparin/heparan sulfate–binding and BMP-binding epitopes, showing the GREM2–BMP2 complex has enhanced heparin affinity, suggesting extracellular matrix interactions regulate GREM2 bioavailability.\",\n      \"evidence\": \"Site-directed mutagenesis of lysine residues, heparin-binding quantification, cell-surface binding, and protein–protein interaction assays\",\n      \"pmids\": [\"28104757\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo significance of heparan sulfate interaction for GREM2 gradient/activity not tested\", \"No structural model of GREM2–BMP complex available\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"GREM2 overexpression in podocytes was shown to shift SMAD signaling from SMAD1/5/8 toward SMAD2/3, promoting apoptosis — revealing a context-dependent pro-apoptotic output of BMP antagonism.\",\n      \"evidence\": \"Overexpression and siRNA in human podocytes, phospho-SMAD Western blots, apoptosis assays, Smad2/3 inhibitor epistasis\",\n      \"pmids\": [\"30831151\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which GREM2 activates SMAD2/3 not defined (direct vs indirect)\", \"In vivo renal phenotype not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Multiple genetic models established GREM2 as a physiological inhibitor of visceral fat browning via BMPR2-dependent SMAD1/5/8 antagonism, while separately its downregulation was shown to be protective in pulmonary arterial hypertension.\",\n      \"evidence\": \"Grem2 overexpression and knockout mice, preadipocyte-specific Bmpr2 KO (PMID:35349825); monocrotaline PAH rat model and human lung samples (PMID:35414785)\",\n      \"pmids\": [\"35349825\", \"35414785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GREM2 acts on brown vs white preadipocytes via identical mechanisms unclear\", \"Human genetic validation of GREM2 in metabolic disease lacking\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Grem2 haploinsufficiency in female mice increased trabecular bone mineral density and osteoblast differentiation markers upon BMP-2 stimulation, confirming GREM2 as a dose-sensitive negative regulator of bone formation.\",\n      \"evidence\": \"Grem2+/- and Grem2-/- mouse models, microCT, DEXA, primary osteoblast culture with BMP-2\",\n      \"pmids\": [\"38839844\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Sex-specific mechanism not explained\", \"Cortical bone unaffected — basis of compartment specificity unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"STAT3 was identified as a direct transcriptional activator of GREM2, linking inflammatory signaling to GREM2 expression in thyroid cells.\",\n      \"evidence\": \"Dual-luciferase reporter assay and siRNA against STAT3 in LPS-stimulated thyroid cell model\",\n      \"pmids\": [\"41322616\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether STAT3→GREM2 axis operates in other tissues not tested\", \"Promoter elements mediating STAT3 binding not mapped at base-pair resolution\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution structure of GREM2 alone and in complex with BMP ligands is lacking, and the mechanism by which GREM2 selectively antagonizes BMP2/4/7 but not activin A remains structurally undefined; additionally, the cardiac-specific in vivo consequences of GREM2 loss in mammals have not been reported.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal or cryo-EM structure of GREM2 or GREM2–BMP complex\", \"Mammalian cardiac knockout phenotype not reported\", \"Relative in vivo contributions of heparan sulfate sequestration vs direct BMP binding not dissected\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [4, 5, 6, 7, 9, 12, 15, 16, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 2, 6, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 4, 5, 6, 7, 12, 15, 16, 17]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [5, 7, 8, 14]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"BMP2\", \"BMP4\", \"BMP7\", \"BMPR2\"],\n    \"other_free_text\": []\n  }\n}\n```"}